Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient
Respirology · 2023
DOI: 10.1111/resp.14487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, 2023. Verfasst von Fraser J H Brims und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Lung Neoplasms, Asbestos. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, Government of Western Australia, National Health and Medical Research Council.
Abstract (Originalsprache)
Background and Objective Asbestos is a major risk factor for lung cancer, with or without tobacco smoke exposure. Low dose computed tomography (LDCT) screening for early lung cancer is effective but only when targeting high risk populations. This study aimed to analyse the effectiveness of LDCT screening in an asbestos exposed population and to compare lung cancer screening program (LCSP) eligibility criteria.
Methods
Participants in an asbestos health surveillance program, the Western Australia Asbestos Review Program, underwent at least one LDCT scan and lung function assessment as part of annual review between 2012 and 2017. Lung cancer cases were confirmed through linkage to the WA cancer registry. Theoretical eligibility for different screening programs was calculated.
Results
Five thousand seven hundred and two LDCT scans were performed on 1743 individuals. The median age was 69.8 years, 1481 (85.0%) were male and 1147 (65.8%) were ever‐smokers (median pack‐year exposure of 20.0). Overall, 26 lung cancers were detected (1.5% of the population; 3.5 cases per 1000 person‐years of observation). Lung cancer was early stage in 86.4% and four (15.4%) cases were never smokers. Based on current lung screening program criteria, 1299 (74.5%) of this population, including the majority (17, 65.4%) of lung cancer cases, would not have been eligible for any LCSP.
Conclusion
This population is at raised risk despite modest tobacco exposure. LDCT screening is effective at identifying early‐stage lung cancer in this population and existing lung cancer risk criteria do not capture this population adequately.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
- National Centre for Asbestos Related Diseases, Institute for Respiratory Health, Perth, Western Australia, Australia.
- ChestRad Medical Imaging, Perth, Western Australia, Australia.
- Envision Medical Imaging, Perth, Western Australia, Australia.
- School of Global and Population Health, University of Western Australia, Perth, Western Australia, Australia.
ORCID-Profile: Fraser J H Brims
Förderung
- Department of Health, Government of Western Australia
- National Health and Medical Research Council
Zitieren
APA
Brims, F. J. H., Harris, E. J. A., Murray, C., Kumarasamy, C., Ho, A., Adler, B., Franklin, P., & de Klerk, N. H. (2023). Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient. Respirology. https://doi.org/10.1111/resp.14487
Vancouver
Brims FJH, Harris EJA, Murray C, Kumarasamy C, Ho A, Adler B, et al. Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient. Respirology. 2023. doi:10.1111/resp.14487
BibTeX
@article{Brims2023,
author = {Brims, Fraser J H and Harris, Edward J A and Murray, Conor and Kumarasamy, Chellan and Ho, Alice and Adler, Brendan and Franklin, Peter and de Klerk, Nick H},
title = {Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient},
journal = {Respirology},
year = {2023},
doi = {10.1111/resp.14487}
}
EUVIMED